CClinicalTrials.gg
Status unknownNCT04809298PunctureCubeUpdated Apr 7, 2022

Comparison of a New Needle Navigation Device for CT-guided Interventions to the Conventional Free-hand Method

An interventional study of Free-hand therapeutic CT-guided punction for lumbar pain and Puncture Cube in Lumbar Pain, sponsored by Luca Remonda. Status unknown at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-04-07.

Sponsored by Luca Remonda · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2022), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 1 year 9 months after the study started (first participant enrolled Jun 2019, registered Mar 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In a prospective, randomized, controlled, parallel group study the accuracy, intervention time and radiation dose of CT-guided punctures using the Puncture Cube® will be compared to the conventional free-hand method in patients requiring a percutaneous diagnostic or therapeutic CT-guided intervention for lumbar pain (facet joint-, nerve root-, epidural infiltrations at the lumbar/lumbosacral level).

Read the detailed description

Computed tomography (CT)-guided interventions for diagnostic and therapeutic purposes are standard approaches in clinical routine (e.g. in patients with low back pain). Numerous CT needle navigation systems have been developed with the aim to improve accuracy (and thus safety) of punctures while decreasing radiation exposure and procedure time. Their usability in clinical routine is limited either because of high sensitivity to interference, high expenses, bulkiness, or incompatibly with daily clinical practice and thus increasing procedure time and workflow complexity. The Puncture Cube® takes into account all these requirements. Furthermore, in an in vitro-phantom study (study submitted for publication), punctures with the Cube were found to be faster and more accurate compared to the free-hand conventional method.

In a prospective, randomized, controlled, parallel group study the accuracy, intervention time and radiation dose of CT-guided punctures using the Puncture Cube® will be compared to the conventional free-hand method in patients requiring a percutaneous diagnostic or therapeutic CT-guided intervention for lumbar pain (facet joint-, nerve root-, epidural infiltrations at the lumbar/lumbosacral level).

02

Conditions studied

  • Lumbar Pain

Browse trials for

03

In context

Low Back Pain

2,817 studies on the registry are indexed under Low Back Pain; 481 are open to participants now.

This study's planned enrollment of 120 is above the median of 60 across 2,268 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

This is the only study on the registry with Luca Remonda as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients requiring a percutaneous therapeutic CT-guided intervention for
  • lumbar pain (joint-, nerve root-, epidural infiltrations at the lumbar/lumbosacral level)
  • age ≥ 18 years
  • Signed informed consent prior to intervention

Exclusion criteria

Exclusion Criteria:

  • Patients suffering from severe obesity (BMI > 30 kg/m2)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Other
    Free-hand lumbar punction

    Diagnostic or therapeutic CT-guided intervention for lumbar pain management using the free-hand method.

    Device: Free-hand therapeutic CT-guided punction for lumbar pain

  • Active comparator
    Puncture Cube

    Diagnostic or therapeutic CT-guided intervention for lumbar pain management using the Puncture Cube® as a needle navigation device.

    Device: Puncture Cube

Interventions

  • DeviceFree-hand therapeutic CT-guided punction for lumbar pain

    Diagnostic or therapeutic CT-guided intervention for lumbar pain management using the Puncture Cube® as a needle navigation device.

  • DevicePuncture Cube

    Diagnostic or therapeutic CT-guided intervention for lumbar pain management using the Puncture Cube® as a needle navigation device.

06

What researchers measure

Primary outcomes

  1. Puncture accuracy

    Assessment of puncture accuracy (distance and angle error between planned and achieved trajectory)

    Time frame: during procedure time approximately 30 min.

Secondary outcomes

  1. Number of control acquisitions to achieve target

    Number of control acquisitions to achieve target

    Time frame: during procedure time approximately 30 min.

  2. Assessment of radiation dose

    Assessment of radiation dose

    Time frame: during procedure time approximately 30 min.

  3. Assessment of intervention time

    Assessment of intervention time

    Time frame: during procedure time approximately 30 min.

07

Study locations

1 of 1 sites recruiting
  • Department of Neuroradiology, Kantonsspital Aarau
    Aarau, Aargau 5001, Switzerland
    • Luca Remonda, Prof. · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04809298
Lead sponsor
Luca Remonda
Responsible party
Luca Remonda (Prof. Dr. med., Kantonsspital Aarau) — Sponsor-investigator
First posted
Mar 22, 2021
Start date
Jun 1, 2019
Primary completion
Dec 31, 2022 (estimated)
Completion
Dec 31, 2022 (estimated)
Last update
Apr 7, 2022

Study contacts

Luca Remonda, Prof.
Contact
luca.remonda@ksa.ch
+41 62 838 43 21
Luca Remonda, Prof.
principal investigator · Department of Neuroradiology, Kantonsspital Aarau

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion